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which critical proteins are released, is tightly regulated by Bcl-2 family proteins. The exact nature
of the release pathway is still undeﬁned. Ceramide is an important sphingolipid, involved in various
cellular processes including apoptosis. Here we describe the structural properties of ceramide chan-
nels and their regulation by the anti-apoptotic and pro-apoptotic proteins of the Bcl-2 family. The
evolutionarily conserved regulation of ceramide channels by Bcl-2 family proteins, consistent with
their role in apoptosis, lends credibility to the notion that ceramide channels constitute the protein
release pathway.
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Apoptosis, a form of programmed cell death, is a complex and
exceedingly important cellular process. A key step in this process
is the release of pro-apoptotic proteins from mitochondria into
the cytosol thus initiating the execution phase of apoptosis. This
is a highly regulated step because it commits the cell, in an essen-
tially irreversible way, to death. This review is focused on a contro-
versial aspect of this process, the identity of the pathway by which
these proteins are released. We present results favoring an uncon-
ventional pathway for this release: channels formed by a unique
sphingolipid, ceramide. The supporting experimental results are
compelling and require a great deal of published research to be
reexamined in a new light. We ask that the reader keep an open
mind and not try to examine the results through the lenses of
existing dogmas.
2. An expanded role for Bcl-2 family proteins
Bcl-2 family proteins regulate the release of proteins from the
mitochondrial intermembrane space and thus regulate a key, deci-
sion-making step in the apoptotic process. There is a general con-chemical Societies. Published by E
ane; ER, endoplasmic reticu-
i).sensus that some of these are pro-apoptotic and others anti-
apoptotic. It is also clear that these proteins act in different ways
to favor or inhibit apoptosis, helping to orchestrate the conditions
needed to achieve apoptosis or to disrupt these conditions. With
time the entire picture will emerge but, until then, it is important
to examine each of these actions with an open mind. Recently, it
was discovered that pro and anti-apoptotic proteins are capable
of regulating the ability of ceramide to form channels both in de-
ﬁned systems and in the mitochondrial outer membrane. This re-
view will focus on this novel aspect of the actions of Bcl-2 family
proteins with the conﬁdence that the evolutionary selection pres-
sure that generated and maintains this emergent property is based
on regulating the onset of apoptosis, ensuring that it occurs only
when the appropriate conditions are present in the cell.
3. Channel formation by the sphingolipid, ceramide
Ceramide is a member of a family of lipids called sphingolipids.
Unlike the more commonly studied membrane lipids referred to as
phospholipids, sphingolipids are not based on esteriﬁcation of
glycerol but on sphingosine and its amide linkage to fatty acids.
The amide linkage, identical to the peptide bond of proteins, has
great potential for hydrogen bonding, having one hydrogen bond
donor and one acceptor. This is perfect for generating assemblies
and ceramide channels are proposed to be formed by a ring of col-
umns each consisting of six ceramides interconnected by the
hydrogen bonds of the amide linkage (Fig. 1). The two hydroxylslsevier B.V. All rights reserved.
Fig. 1. A model of the structure of a ceramide channel. The ceramide channel is a water-ﬁlled cylinder that spans the membrane. It is composed of a variable number of
columns each consisting of six ceramide molecules. One of the columns is colored in gold to illustrate the fundamental unit. Ceramides within a column are held together by
hydrogen bonds (green) between the amide linkages. Adjacent columns have an anti-parallel orientation as shown in the enlarged section. Note that in the enlarged region,
the hydrogens were not included for clarity. Channel growth is achieved by the incorporation of additional columns. Color coding: red – oxygen, blue – nitrogen, grey – carbon
and white – hydrogen.
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necting adjacent columns. Indeed, from model building one can
conclude that the inner surface of the channel is lined with a hy-
droxyl–hydrogen-bonded network, interfacing nicely with the
aqueous phase. As is the case for the alpha helix of proteins, align-
ing the amide linkages results in a long dipole. Imbedded in the
low dielectric constant of the membrane, the inﬂuence of the di-
pole will be stronger and extend over longer distances. Experi-
ments [1] strongly support the notion that this dipole forces the
columns to be arranged in an anti-parallel fashion.
Addition of ceramide to phospholipid membranes results in the
formation of a conductance pathway, a permeability that grows
with time ﬁnally reaching a steady value (Fig. 2). This indicates
the formation of a channel that starts out small and becomes larger
as more ceramides are recruited. The conductance increases range
from small and non-descript to large discrete events indicating
insertions ranging from small aggregates or individual monomers
to assemblies of pre-formed columns. The ﬁnal steady value likelyFig. 2. The formation of a ceramide channel following the addition of C16-ceramide
to the aqueous phase bathing a phospholipid membrane. The medium consisted of
1.0 M KCl, 1 mM MgCl2, 5 mM PIPES pH 6.9. The membrane was composed of
diphytanoylphosphatidyl choline:asolectin:cholesterol, 1:1:0.1.reﬂects a dynamic equilibrium between ceramide molecules in the
structure of the channel and ceramide monomers or non-channel
forming ceramide aggregates in the membrane. This is supported
by observing increases and decreases in conductance even after a
steady value is achieved. In addition, channel disassembly can be
induced by removing ceramide monomers from the medium when
short-chain ceramide was used [2] to form the channel. (The short-
chain ceramide is sufﬁciently water-soluble that the addition of
fatty-acid depleted albumin can bind it and cause channel disas-
sembly by mass action.) Experiments are consistent with a
highly-organized and rigid structure, deriving its stability from
hydrogen bonding. Presumably, on average the intrastructural
hydrogen bonds are somewhat more stable that those with water
allowing an enthalpic advantage to overcome what is likely an
entropic disadvantage. A very small free energy change arising
from bonding associated with a single ceramide unit would be
greatly magniﬁed by the hundreds of ceramides forming one chan-
nel. Channel growth results in the formation of more intrastructur-
al hydrogen bonds but also results in a change in channel curvature
and thus changes in the length and angle of these bonds (i.e. bond
energy). It may be that an optimal curvature exists, below and
above which the bonding is less stable. The overall structure is
destabilized by addition of lanthanum ions. By mechanisms yet un-
known, lanthanum chloride induces channel disassembly in dis-
crete steps without affecting the ceramide concentration in the
membrane [1]. The high charge density of this trivalent cation
would be expected to strongly inﬂuence the structure and stability
of a ceramide channel if it bound to the its polar inner surface:
from electrostatic repulsion between nearby bound La+3 ions to
disrupting/distorting the hydroxyl–hydrogen-bonded network
forming the polar lining of the channel following ligation of the
ion by the ceramide hydroxyls.
The loss of ceramide conductance following the addition of
LaCl3 occurs in a way that directly demonstrates that only one
large ceramide channel is formed in the phospholipid membrane.
When low levels of LaCl3 were added (2 lM ﬁnal), the conductance
declined but only after a delay that was generally far longer than
the diffusion time for lanthanum to reach the membrane. Further-
more, the delay was variable in duration among the various exper-
iments [1]. Thus the delay was stochastic or probabilistic, a
Fig. 3. Disassembly of a ceramide channel formed in a phospholipid membrane by
the addition of the anti-apoptotic Bcl-2 family protein, Bcl-xL. FL refers to Full
Length, implying that the Bcl-xL used is a wild-type protein without any
modiﬁcations. This is used to distinguish it from other mutants that have deleted
domains. The conductance of the membrane induced by addition of C16-ceramide
was measured as a function of time. The medium consisted of 1.0 M KCl buffered to
pH 7.0. See Ref. [6] for further details.
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ulation of channels would result in an exponential decay of con-
ductance as each individual channel lost its conductance. Such an
exponential decay was generated by pooling together results from
more than 30 experiments so as to artiﬁcially generate a popula-
tion of channels. Thus, the stochastic behavior of individual exper-
iments demonstrates that the ceramide conductance represents
the growth of a single large channel in the membrane.
This conclusion was supported by other observations. For
example, selectivity measurements of membranes with low cera-
mide conductance showed substantial cation preference. When
more ceramide was added to increase the conductance the selec-
tivity declined and ﬁnally became non-selective. If the increase
in conductance had been due to the formation of more ceramide
channels then the selectivity should not have changed. If the addi-
tional ceramide was incorporated into the existing channel result-
ing in channel enlargement, the selectivity would decline because
ions traversing the channel would interact less with the channel
wall [1].
4. Ceramide channel formation in the mitochondrial outer
membrane (MOM)
Channel formation in the MOM can be detected by measuring
the release of proteins [2–5] but permeabilization of the outer
membrane can be measured [2] by recording the rate of oxidation
of exogenously added cytochrome c by cytochrome oxidase (active
site on the outer surface of the inner membrane). This cytochrome
c accessibility assay measures the permeabilization of the outer
membrane to proteins. This can be measured at any time during
an experimental protocol and the initial rate of oxidation will mea-
sure the permeability at that time. One can follow both an increas-
ing permeability as channels form and a decreasing one as they are
disassembled [6].
The dispersal of ceramide (dissolved in isopropanol) into a
mitochondrial suspension results in a gradual permeabilization of
the outer membrane to cytochrome c with a half time of about
5 min [2]. The permeabilization occurs at the elevated ceramide
levels that are found in mitochondria early in apoptosis [7,8]. From
adenylate kinase release experiments [2], it is clear that at the lev-
els of ceramide used in these experiments, only a portion of the
mitochondria become permeabilized because only a portion of
the adenylate kinase was released. Thus the permeabilized mito-
chondria probably contain only one or at most two channels and
this realization is important in interpreting the results of ceramide
channel modiﬁers.
The probability of ceramide channel formation and the stability
of existing channels are at the mercy of the steady-state concentra-
tion of ceramide in the membrane. The latter is, of course, deter-
mined by the rates of ceramide synthesis, degradation, and
transfer between membranes. In the mitochondrial outer mem-
brane, where these channels form, there are enzymes capable of
both ceramide synthesis and hydrolysis [9–11]. The tight interac-
tion between the MOM and endoplasmic reticulum (ER) mem-
branes provides the opportunity for ceramide exchange, as
already demonstrated [12], between the major location of cera-
mide de novo synthesis (the ER) and the MOM. Thus, there are am-
ple opportunities to regulate the steady-state level of ceramide in
the MOM and indeed this level becomes elevated early in apoptosis
in a number of systems However, other sphingolipids can also
inﬂuence channel formation and stability. Both dihydroceramide
and sphingosine interfere with ceramide channel formation
[13,14]. Finally, and most importantly, Bcl-2 family proteins can
also inﬂuence the stability of ceramide channels, probably through
inﬂuencing the dynamic equilibrium between ceramides in a chan-
nel structure and ceramide in other forms [4,15].5. The anti-apoptotic protein, Bcl-xL, favors channel
disassembly
Bcl-xL (26 kDa) is an anti-apoptotic Bcl-2 family protein struc-
turally classiﬁed as having four Bcl-2 homology (BH) domains. It
acts directly on ceramide channels formed in phospholipid mem-
branes causing them to disassemble [4]. The pure, full-length
Bcl-xL protein was expressed in Escherichia coli and only the pro-
tein that remained soluble in the cytosol was used. Denatured pro-
tein in inclusion bodies was not used. No detergent was used in the
puriﬁcation process as this was found to cause spurious effects [4].
Addition of the Bcl-xL protein to a preformed ceramide channel re-
sulted in rapid channel disassembly until all the membrane perme-
ability was lost. The conductance did not immediately drop to
baseline as would be expected for a blocking of the channel
(Fig. 3). Rather there was a structured reduction in conductance
consistent with a time-dependent channel disassembly. It is
important to note that published results [1] provide compelling
evidence that a single ceramide channel is formed in the mem-
brane. The disassembly following Bcl-xL addition is consistent with
there being a single channel because the record is consistent with a
single process. In addition, the calculated size of the ceramide
channel based on the conductance as compared to the size of
Bcl-xL means that Bcl-xL binding to the inside of the channel
would only reduce the conductance by a small value (ineffective
block). More insight into the mechanism of disassembly comes
from experiments performed on isolated mitochondria.
6. Anti-apoptotic proteins inhibit ceramide permeabilization of
the mitochondrial outer membrane
The permeabilization of the MOM to cytochrome c by ceramide
is inhibited by the addition of Bcl-xL [4]. This inhibition is indepen-
dent of the sequence of addition (Fig. 4). Pre-incubation of rat liver
mitochondria with Bcl-xL inhibits the ability of C16-ceramide to
permeabilize the outer membrane to cytochrome c. The degree of
inhibition depends on the amount of added Bcl-xL. Importantly,
the same levels of permeabilization were observed (Fig. 4) even
when the MOM was ﬁrst permeabilized by adding the ceramide.
Thus, not only did the Bcl-xL reverse the ceramide-induced perme-
abilization but the same end point was achieved, indicating that an
equilibrium was reached. A ﬁt of the inhibition curve to the Hill
Fig. 4. Bcl-xL reduces the ceramide-mediated permeabilization of the outer
membrane of mammalian mitochondria. The same amount of C16-ceramide was
added to all experiments. In one set of experiments, ceramide was added ﬁrst and
allowed to achieve the maximal permeabilization. This was followed by the
addition of Bcl-xL. In the other set, Bcl-xL was added ﬁrst. Regardless of the
sequence of addition, the same ﬁnal permeability was observed. The permeabili-
zation of the outer membrane to cytochrome c is expressed as a percent of the
maximal permeabilization achieved by damaging the outer membrane with a mild
hypotonic shock. Reprinted from Ref. [6].
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1:1 complex between Bcl-xL and the channel. The possibility exists
that Bcl-xL is acting as a channel blocker but because of the large
excess of Bcl-xL over the estimated number of channels in the
mitochondria, any blocking action must be transient, resulting
from the binding and unbinding of Bcl-xL. Considering the results
of the phospholipid membrane experiments, a blocking mecha-
nism seems unlikely. The possibility that Bcl-xL forms hetero-olig-
omers with non-channel-forming ceramide complexes thus
favoring these and causing ceramide disassembly by mass action,
also seems unlikely because the molar amount of ceramide present
was 3 orders of magnitude larger than Bcl-xL. In addition, such a
scenario could not explain the Hill coefﬁcient. A more likely mech-
anism would be an effect of Bcl-xL binding on the channel stability.
If the binding of Bcl-xL were to distort the structure of the channel,
then the distortion would spread throughout the hydrogen-bonded
structure. This would result in a shift in the dynamic equilibrium
between ceramides forming the channel and those in other forms
in the membrane.
That Bcl-xL is acting speciﬁcally was shown by testing a variety
of Bcl-xL truncation mutants that had previously been tested for
their ability to inﬂuence the apoptotic process [16,17]. The mu-
tants known to be ineffective on apoptosis were also ineffective
on the ceramide-induced permeabilization of the MOM. One mu-
tant that converted Bcl-xL to a pro-apoptotic protein, increased
the ability of ceramide to permeabilize the MOM. Thus altered ver-
sions of Bcl-xL behave as expected, attesting to the speciﬁcity of
the effect of Bcl-xL on ceramide channels.
Apoptosis in Caenorhabditis elegans is also associated with mito-
chondrial outer membrane permeabilization and regulated by Bcl-
2 family proteins that are homologous to mammalian equivalents.
CED-9, the nematode homolog of mammalian Bcl-xL, localizes to
mitochondria to inhibit apoptosis. In isolated rat liver mitochon-
dria, CED-9, also inhibits the ability of ceramide to permeabilize
the mitochondrial outer membrane and does so in a dose-depen-
dent manner [4]. This shows that the inhibition is not conﬁned
to Bcl-xL but extends to other anti-apoptotic proteins.
Experiments with yeast (Saccharomyces cerevisiae) mitochon-
dria provide evidence for a speciﬁc interaction between anti-apop-
totic proteins and ceramide channels. Since yeast do not produce
proteins equivalent to the Bcl-2 family, mitochondria from yeastcells have been used as a ‘‘clean” system in which to study the
interactions between ceramide channels and anti-apoptotic pro-
teins. Interference from other Bcl-2 family proteins cannot occur.
Human Bcl-2 expressed in yeast travels to the MOM. Isolated mito-
chondria from yeast expressing Bcl-2 have Bcl-2 incorporated into
their membranes as shown by western blot. These mitochondria
are resistant to permeabilization by ceramide as compared to
mitochondria isolated from control cells [4]. Bcl-xL added to con-
trol yeast mitochondria inhibits ceramide permeabilization in the
same way as it does in experiments with mammalian mitochon-
dria. Again, the dose dependence shows a Hill coefﬁcient close to
1 and Bcl-xL truncation mutants act as expected [4]. These results,
as well as the results of experiments performed on phospholipid
membranes, provide strong evidence that anti-apoptotic proteins
are acting directly on ceramide channels to destabilize them.
7. The pro-apoptotic protein, Bax, and its role in mitochondrial
outer membrane permeabilization
Bax is a 21 kDa monomeric cytosolic pro-apoptotic Bcl-2 family
protein that has only three of the four BH domains, hence classiﬁed
as a BH1-3 type Bcl-2 protein, as compared to BH3 only pro-apop-
totic proteins, that have only the BH3 domain. That structure of
Bax is characteristic of BH1-3 pro-apoptotic proteins [18]. It is typ-
ically located in the cytosol but translocates to mitochondria early
in the apoptotic process. This translocation is followed by confor-
mational changes often referred to as Bax activation that eventu-
ally lead to mitochondrial outer membrane permeabilization to
proteins or MOMP. Typically the conclusion is that Bax itself forms
the channel that allows protein permeabilization or that Bax acts
with another pro-apoptotic protein called Bak to form the path-
way. However, there is evidence for the role of ceramide associated
with the Bax activity. Several studies have found that increasing
mitochondrial ceramide results in Bax translocation to mitochon-
dria and subsequent activation [7,19,20]. This translocation and/
or activation of Bax by ceramide does not require other cytosolic
factors as this also happens in isolated mitochondria [19]. In fact,
Bax has been found to localize to ceramide enriched microdomains
of mitochondria [21]. But these studies have not resolved the exact
role of ceramide in activating Bax or inducing MOMP. Is ceramide a
structural component of the MOMP channel along with Bax? Or
does it act as a second messenger to activate Bax? Both ceramide
and Bax are independent channel formers in membranes. So, under
circumstances where both ceramide and Bax are present, which
molecule forms the protein permeable MOMP channels? Results
are consistent with the conclusion that activated Bax and ceramide
can synergistically induce permeabilization of MOM. This synergy
was also observed in yeast mitochondria and planar phospholipid
membranes [15].
8. Bax and ceramide act synergistically
When isolated mitochondria were pretreated with Bax acti-
vated either with the detergent octyl glucoside, or with an acti-
vated form of the BH3 only protein, Bid, (a protein that activates
Bax in vivo and in vitro) these mitochondria are much more sensi-
tive to C16-ceramide permeabilization. The degree of permeabiliza-
tion is greater than the combined effect of each treatment alone
(Fig. 5). This synergy indicates a possible direct interaction be-
tween Bax and ceramide, perhaps cooperativity in channel forma-
tion. When tested on phospholipid membranes, activated Bax
alone did not form channels easily and similarly for C16-ceramide.
When both were present, channel formation seemed to occur more
readily, indicating a lowering of the energy barrier for permeabili-
zation. More importantly, the addition of activated Bax to a cera-
Fig. 5. Bax activated by either processed Bid (N/C Bid) (A) or detergent (0.7% octyl glucoside) (B) acts synergistically with C16-ceramide to permeabilize the mitochondrial
outer membrane to cytochrome c. The permeabilization resulting from the presence of both ceramide and activated Bax simultaneously is higher than the sum of the
permeabilizations induced by either activated Bax or ceramide alone. The statistical signiﬁcance is at the 99% level for (A) and at the 95% level for (B). Reprinted from Ref. [15].
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This increase was the result of the growth of the preformed chan-
nel because disassembly of the combined channel with lanthanum
chloride resulted in channel disassembly with stochastic behavior.
There was a delay of variable length followed by a structured dis-
assembly [15]. As described for the ceramide channel, such sto-
chastic behavior is characteristic of a single structure. This
behavior is not consistent with the presence of multiple pathways
or separate pathways for ceramide and Bax but rather with one
pathway, one channel.
Insight into the nature of this synergistic interaction was ob-
tained with dose–response experiments on isolated mitochondria.
The ceramide-induced permeabilization increases monotonically
with the level of activated Bax used to preincubate the mitochon-
dria. However, this is only the case at low levels of added ceramide,
i.e. levels that produced a very small amount of permeabilization.
Regardless, the monotonic increase reaches a saturating level of
permeabilization suggesting a stoichiometric interaction between
activated Bax and ceramide. Interestingly, the concentration of
activated Bax at which this saturating permeabilization is achieved
depends on the amount of added ceramide. As the amount of
added ceramide increases, the activated Bax concentration at
which the saturation of permeabilization is achieved decreases.
In other words, when more ceramide is present, a lower concentra-
tion of Bax is required to achieve maximal MOMP, indicating thatFig. 6. Activated Bax (ac-Bax) induces a large increase in the size of a ceramide
channel formed in a phospholipid membrane. Addition of monomeric Bax (m-Bax)
had no effect. The addition of LaCl3 induced channel disassembly. Reprinted from
Ref. [15].the afﬁnity of activated Bax for ceramide might increase as the
amount of ceramide increases. A Hill analysis was used to deter-
mine the apparent afﬁnity between the ceramide channel and acti-
vated Bax. A plot of the Bax concentration that resulted in half-
maximal effect versus the amount of ceramide added showed that
the apparent afﬁnity does increase with increasing amounts of cer-
amide (Fig. 7). It must be remembered that as the amount of added
ceramide increases, the permeabilization induced by ceramide also
increases. So, it is likely that activated Bax is affecting the perme-
abilizing structure formed by ceramide. This is consistent with the
observation that at high ceramide levels, activated Bax does not in-
duce any further stimulation of ceramide induced MOMP. These
observations are not readily explained by the hypothesis that cer-
amide acts by enhancing Bax activation. On the contrary, these re-
sults lend themselves to the conclusion that activated Bax acts on a
ceramide channel and increases its size. When an activated Bax
molecule binds to a ceramide channel, the channel could come un-
der stress, a stress that is relieved by the expansion of the channel.
This expansion goes on until the channel is of an optimum size
with a radius of curvature that matches something in the structure
of activated Bax. This conjecture explains why permeabilization byFig. 7. K0.5, the concentration of activated Bax that produces a half-maximal
enhancement of the ceramide permeabilization of the mitochondrial outer mem-
brane to cytochrome c, declines with increasing dose of ceramide. K0.5 was obtained
from a Hill analysis of the data. Each set of data points represents an experiment
performed on a different day with a different mitochondrial preparation from rat
liver (total of 4 independent experiments). As the amount of added C16-ceramide
was increased, less activated Bax was required to achieve the same level of
permeation enhancement. This result is consistent with the model of activated Bax
enlarging a ceramide channel by binding more tightly with a channel of larger size.
Reprinted from Ref. [15].
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vated Bax. If the channel formed by ceramide itself is large enough,
the binding of activated Bax might be accommodated by the chan-
nel completely and thus there would be no stress to drive the chan-
nel to a larger size.
According to this model, activated Bax and ceramide are struc-
tural components of the same MOMP channel, but the combined
channel retains some of the properties of the ceramide channel.
Consistent with this, we found that trehalose, a disaccharide that
speciﬁcally inhibits ceramide induced permeabilization also inhib-
its the combined permeabilization of ceramide and activated Bax.
This model predicts that the interaction between activated Bax
and ceramide is direct. This is certainly true because the interac-
tion exists when tested in phospholipid membranes. Another
requirement of this model is that activated Bax and ceramide form
a single permeabilizing structure. This condition was also veriﬁed
in the phospholipid membrane system where the disassembly of
the permeabilizing structure formed by activated Bax and cera-
mide by lanthanum chloride was shown to be stochastic event
[15], indicating a single structure. The molecular nature of this
combined channel is difﬁcult to imagine because the components
are so different in size and structure.
9. Physiological relevance of ceramide channels
Ceramide is a vital sphingolipid that participates in a slew of
cellular events including cell senescence, apoptosis, differentia-
tion, cell cycle arrest and raft formation during cell signaling
[22]. Focusing on apoptosis, exogenously-added ceramide has
been found to be able to induce apoptosis in a variety of cell types.
Moreover, cellular ceramide levels rise in response to various
apoptotic stimuli [23–27] so endogenous levels often rise when
apoptosis is induced. Since ceramide is virtually insoluble in water,
it can be isolated in different membrane compartments. The mito-
chondrion is a particularly important site where an increase in the
ceramide level is associated with apoptosis [7,19,27,28]. While
mitochondria are equipped with their own ceramide synthesizing
machinery [9,28], migration of acid sphingomyelinase to mito-
chondria has been observed in response to UV irradiation [29]
resulting in elevation of mitochondrial ceramide. The localization
of ceramide to the MOM during apoptosis is also correlated with
MOMP [7,19]. Several studies have found that isolated mitochon-
dria can be permeabilized by adding ceramide [2,6,12,30]. Tar-
geted elevation of mitochondrial ceramide can also lead to
mitochondrial permeabilization and the subsequent steps of apop-
tosis [31]. Anti-apoptotic Bcl-2 proteins, namely Bcl-2 and Bcl-xL
have been found to negatively regulate ceramide synthesis during
apoptosis [32–34]. Thus the case for ceramide’s importance in
causing apoptosis in cells is very strong. The aspect where there
is lack of consensus is that ceramide channels are involved in
MOMP.
The association of ceramide with Bcl-2 family proteins in the
context of apoptosis is also very strong. The mechanistic basis for
this association will turn out to be complex. One aspect, mentioned
above, is that mitochondrial ceramide acts as a platform for Bax
translocation and activation [7,19,21]. Other observations can be
understood within the context of Bcl-2 family proteins acting on
ceramide channels. Traditionally, the mechanism of Bcl-xL medi-
ated inhibition of MOMP has been assumed to be entirely mediated
by direct and indirect inhibition of Bax activation by BH3 only pro-
teins, some of which directly activate Bax while some others
sequester anti-apoptotic proteins. However, studies with mutants
of Bcl-xL that do not bind to any Bcl-2 family proteins [35–37],
which would be expected to not affect permeabilization, still inhi-
bit MOMP, suggesting that additional levels of regulation exist by
which Bcl-xL can inhibit MOMP. The effect of Bcl-xL on the cera-mide channel qualiﬁes as an additional regulatory step. Regarding
Bax, it is known that activated Bax can induce protein release from
isolated mitochondria without requiring ceramide [37–39] but
activated Bax induced protein release in isolated mitochondria oc-
curs over unphysiological timescales of several hours. No real-time
permeabilization is detected with Bax [38]. There is a considerable
time gap between Bax translocation to the MOM and the induction
of permeabilization [40,41]. Additional signals apart from those
that cause Bax translocation are necessary to induce the conforma-
tional changes in Bax associated with MOMP [41,42]. Studies have
also found that most of the Bax translocates to MOM downstream
of MOMP [43–45]. Valentijn et al. [42] show that Bax inserts into
the MOM through a C-terminal targeting signal but that Bax can in-
sert into the MOM even in the absence of this targeting signal once
the mitochondria have been permeabilized, in a caspase indepen-
dent manner. These authors and others [46] have concluded that
activated Bax is a receptor for cytosolic Bax. However, it is also
likely that cytosolic Bax binds to ceramide channels downstream
or concomitant with MOMP in a target-signal-independent fash-
ion, especially because a constitutively membrane localized Bax
mutant that cannot induce permeabilization does not recruit cyto-
solic Bax to membranes. The results can now be interpreted con-
sidering the possibility of interaction with ceramide channels
and our results hence spawn new a new line of thinking. In a sys-
tem that normally lacks Bcl-2 family proteins, cell death can be in-
duced in yeast by the over-expression of Bax but this cell death
was inhibited when ceramide levels were reduced by co-expres-
sion with sphingomyelin synthase [47]. The interplay between cer-
amide and Bax in this highly simpliﬁed system is compelling. There
is still further evidence for interplay between ceramide and pro-
apoptotic proteins. While either Bax or Bak has been found to be
mandatory for the induction of apoptosis in response to various
stimuli, acid sphingomyelinase knockout cells (reduced ability to
generate ceramide) are resistant to UV induced apoptosis even in
the presence of both Bax and Bak [19,48]. Finally, although cells
deﬁcient in both Bax and Bak are very refractory to pro-apoptotic
signals, these signals also fail to elevate cellular levels of ceramide.
The failure to raise the cellular ceramide level is due to the fact the
Bax is necessary to elevate the activity of ceramide synthase [49].
10. Conclusion
The hypothesis that ceramide channels are involved in protein
release from mitochondria early in apoptosis is strongly supported
by the regulation of these channels by the Bcl-2 family proteins.
The regulation observed is in the direction concurrent with their
role in apoptosis: anti-apoptotic proteins inhibit ceramide chan-
nels while the pro-apoptotic proteins enhance these channels. It
is indeed remarkable that inhibiting ceramide channels is an evo-
lutionarily conserved property of Bcl-2 type anti-apoptotic pro-
teins across species (Bcl-xL of mammals and CED-9 of C. elegans).
In addition Bax affects the ceramide channel at concentrations
where by itself it has minimal effect on the permeabilization of
mitochondria. This indicates that the interaction with the ceramide
channel is physiologically more important than acting on its own.
Thus, in the process of developing a global understanding of the
apoptotic process, one must include ceramide channels as an
intrinsic and probably a key component.
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